The chart is not accessible to screen readers. Please switch to the table view to access the data.
In 2024, pharmaceutical laboratories reported a revenue of nearly *** million euros from the sale of Ozempic and its analogs in Spain, a figure ** times higher than that recorded in 2019. This exponential growth is a direct consequence of the increase in sales of these anti-diabetic drugs, whose recent boom is largely due to their use as a treatment for obesity.
Log in or register to access precise data.
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
About the industry
About the region
Selected statistics
Other regions
Related statistics
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
